-
Janower family drives pediatric brain tumor research forward
Cindy and AJ Janower’s introduction to the challenging world of childhood cancer began when their daughter, Samantha “Sammi,” was just three years old.
-
Collaboration catalyst: Unique gift builds culture ahead of historic partnership
Randi and Joel Cutler set about structuring a $2 million gift to be shared equally between Dana-Farber Cancer Institute and BIDMC—the first-ever joint gift in support of the two Harvard teaching institutions.
-
Breast Cancer Research Foundation grants more than $4 million to speed Dana-Farber research
Building on past support, BCRF recently made grants totaling more than $4 million to 12 physician-scientists at Dana-Farber.
-
Freedman named to David Goldstein Chair
Matthew Freedman, MD, was named the inaugural incumbent of the David Goldstein Chair at Dana-Farber, endowed by the late Jonathan Goldstein to support kidney cancer research in memory of his father, David Goldstein.
-
Damon Runyon Cancer Research Foundation invests in tomorrow’s discoveries
Dana-Farber received over $3,156,000 in grants from the Damon Runyon Cancer Research Foundation in 2024 supporting 10 physician-scientists and researchers.
-
HomeGoods expands support to enhance patient care
Through HomeGoods’ Find Home Anywhere mission—funded largely by donations from its generous shoppers—HomeGoods and the TJX Foundation have made a three-year commitment to donate at least $3.6 million to Dana-Farber.
-
Dana-Farber’s neuro-inclusive program sets new standard in cancer care
In March 2024, Dana-Farber launched the Neuro-Inclusive Oncology Care and Empowerment Program to provide specialized cancer care for adults with intellectual and/or developmental disabilities (IDD). The establishment of the program was made possible by a combined gift of $2.64 million from the C.J.L. Charitable Foundation and the Nancy Lurie Marks Family Foundation.
-
Defeating treatment-resistant lung cancer
A collaborative, multi-institution team led by Dana-Farber’s David Barbie, MD, received a four-year, $2.5 million grant from the International Association for the Study of Lung Cancer (IASLC) and Lung Cancer Research Foundation (LCRF) for researching a cure for non-small cell lung carcinoma.
-
Reaching across the globe to advance prostate cancer research
Through annual gifts and a bequest, Mayer has made a significant gift commitment, establishing The Ross Mayer Endowed Fellowship in Prostate Cancer and the accompanying Mayer Fellow Advancement Fund.
-
Bekensteins endow investigatorship in honor of Meredith and Billy Starr
The Bekensteins recently made a generous gift to the Institute to establish the Meredith and Billy Starr Investigatorship.










